Hot Investor Mandate 3: Healthcare Asset Manager Dedicates New Fund to Early Stage Medtech

19 Jan

A healthcare asset management institution based in Beijing, China manages more than 20 healthcare equity investment funds and is currently investing from its US$50 million fund focusing on early stage opportunities from North America. The firm prefers to follow a syndicate in Angel and Pre-Series A rounds. Typical investment ranges from US$0.5 to 1 million.

The firm is interested in medical devices and diagnostic technologies that have large market potential in China. The firm prefers products in pre-clinical and clinical development stage. The firm is agnostic to indication areas.

The firm is looking for experienced management teams with strong sector knowledge. Leveraging its network and portfolio companies, the firm can assist with finding local registration and distribution partners and may request regional rights in China.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: